Co-Authors
This is a "connection" page, showing publications co-authored by DEANNA LYNN LANE and ROSALIND PITPITAN CANDELARIA.
Connection Strength
1.039
-
Mid-treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer. Ultrasound Med Biol. 2022 06; 48(6):1010-1018.
Score: 0.206
-
Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients. Eur J Radiol. 2020 Sep; 130:109170.
Score: 0.183
-
Imaging features of triple-negative breast cancers according to androgen receptor status. Eur J Radiol. 2019 May; 114:167-174.
Score: 0.168
-
Defining Breast Cryoablation Treatment Success: A?Guide for the Curative and Palliative Treatment of Breast Cancer. Acad Radiol. 2024 Dec; 31(12):4759-4771.
Score: 0.061
-
Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Front Oncol. 2023; 13:1264259.
Score: 0.058
-
Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer. Cancers (Basel). 2023 Oct 02; 15(19).
Score: 0.057
-
Breast Cancer Cryoablation Fundamentals Past and Present: Technique Optimization and Imaging Pearls. Acad Radiol. 2023 10; 30(10):2383-2395.
Score: 0.056
-
Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI. Cancers (Basel). 2023 Feb 06; 15(4).
Score: 0.055
-
Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer. NPJ Breast Cancer. 2023 Jan 10; 9(1):2.
Score: 0.055
-
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer. J Magn Reson Imaging. 2021 07; 54(1):251-260.
Score: 0.048
-
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Breast Cancer Res Treat. 2021 Jan; 185(1):1-12.
Score: 0.046
-
Proliferative fasciitis mimicking sarcoma in the breast. Breast J. 2020 10; 26(10):2072-2074.
Score: 0.046